Expertise in
6
conditions

Darrell H. Tan

St. Michael's Hospital, 
Toronto, ON, CA 
Expertise in
6
conditions
St. Michael's Hospital, 
Toronto, ON, CA 

Overview

Darrell Tan practices practicing medicine in Toronto, Canada.

Mr. Tan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Syphilis, Monkeypox, and Genital Herpes.

He is actively involved in clinical research, co-authoring 191 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

St. Michael's Hospital, Toronto, ON, Canada
Other Locations
St. Michael's Hospital, Unity Health Toronto, Toronto, Canada
Scarborough, ON, Canada
Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
Virtual PrEP: Rendering PrEP Delivery More Efficient Using an mHealth Intervention and TAF/FTC
Virtual PrEP: Rendering PrEP Delivery More Efficient Using an mHealth Intervention and TAF/FTC
Enrollment Status: Terminated
Publish Date: April 18, 2024
Intervention Type: Other, Drug
Study Phase: Phase 4
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
Enrollment Status: Unknown
Publish Date: December 14, 2021
Intervention Type: Drug
Study Drug: Lopinavir/ritonavir
Study Phase: Phase 3
Enhanced Syphilis Screening Among HIV-positive Men (ESSAHM): Evaluation of a Clinic-based Intervention
Enhanced Syphilis Screening Among HIV-positive Men (ESSAHM): Evaluation of a Clinic-based Intervention
Enrollment Status: Completed
Publish Date: July 26, 2018
Intervention Type: Other
Study Phase: Not Applicable
Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Enrollment Status: Completed
Publish Date: April 19, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

191 Total Publications

Monkeypox-Associated Disciform Keratitis: Retraction.
Monkeypox-Associated Disciform Keratitis: Retraction.
Journal: Cornea
Published: July 17, 2026

Frequently Asked Questions about Darrell H. Tan

Is Darrell H. Tan a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Darrell H. Tan is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Darrell H. Tan participate in research or clinical trials?

Yes. Darrell H. Tan has published 191 articles and abstracts on conditions like HIV/AIDS. You can view a list of Darrell H. Tan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tan's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile